2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
134
Precursor Cell Lymphoblastic Leukemia-Lymphoma
116
Myelodysplastic Syndromes
112
Leukemia, Lymphocytic, Chronic, B-Cell
102
Lymphoma, Non-Hodgkin
98
Hodgkin Disease
95
Leukemia
86
Multiple Myeloma
85
Lymphoma
72
Lymphoma, Mantle-Cell
67
Lymphoma, Follicular
67
Lymphoma, Large B-Cell, Diffuse
64
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
60
Myeloproliferative Disorders
58
Lymphoma, B-Cell, Marginal Zone
58
Burkitt Lymphoma
53
Leukemia, Myelomonocytic, Chronic
51
Congenital Abnormalities
51
Leukemia, Myeloid, Chronic-Phase
49
Lymphoma, Large-Cell, Immunoblastic
46
Leukemia, Myeloid, Accelerated Phase
43
Hematologic Neoplasms
42
Anemia, Refractory, with Excess of Blasts
40
Graft vs Host Disease
39
Primary Myelofibrosis
36
Waldenstrom Macroglobulinemia
34
Neoplasms, Plasma Cell
33
Blast Crisis
33
Recurrence
30
Lymphoma, T-Cell, Cutaneous
30
Interventions
telitacicept
3
fludarabine
3
Prednisone
3
Data Collection
3
Cyclophosphamide
3
Specimen Handling
2
Nivolumab
2
Blood Specimen Collection
2
Antilymphocyte Serum
2
thymoglobulin
1
remdesivir
1
prednylidene
1
human papillomavirus vaccine, L1 type 16, 18
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
cabozantinib
1
apremilast
1
Watchful Waiting
1
Vitamin D
1
Valsartan
1
Telemedicine
1
Surveys and Questionnaires
1
Standard of Care
1
Pyridostigmine Bromide
1
Practice Guidelines as Topic
1
Population Groups
1
Platinum Compounds
1
Plasma Exchange
1
Phlebotomy
1
Peripheral Blood Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Autoimmune Diseases
×
Mycophenolic Acid
×
Clear all
NCT03490539
2021-02-03
PROMISE-MG
Duke University
Completed
167 enrolled